Who might benefit most from a personalized treatment plan to support brain health?

"Individuals vary in their resilience or vulnerability to Alzheimer’s disease", said Professor James Galvin, Miami, FL, at ADPD2022. Resilience may offer protection from a poor environment, whereas vulnerability may be buffered by modifying environmental risk factors. He described tools he has developed with his team to measure such resilience and vulnerability, and Dr Camilla Cividini, Milan Italy, presented a study revealing the most vulnerable areas of the brain.

Which areas of the brain are most vulnerable to Alzheimer’s disease?

Late-maturing regions of the brain are most vulnerable to aging

Dr Cividini presented a study she carried out with colleagues to investigate typical cortical thinning changes in aging healthy brains that might reveal vulnerability to neurodegeneration.

The team carried out magnetic resonance imaging on 128 healthy individuals and estimated cortical thickness in 83 regions and the cortical thickness trajectory with increasing age.1

"Cortical thinning was most evident in the temporal, frontal and parietal lobes", said Dr Cividini, "and least evident in occipital regions and motor and premotor areas".1

It’s never too early or too late to take action to prevent Alzheimer’s disease

The results from the study are consistent with the “last-in, first-out” hypothesis in which late-maturing regions of the brain are most vulnerable to aging, concluded Dr Cividini. Such thinning in the temporal, frontal and parietal lobes might therefore have a crucial role as an additive risk factor for age-related neurodegeneration.1

 

Brain resilience vs vulnerability to Alzheimer’s disease

"How can we build a better brain as we get older?" asked Professor James Galvin, University of Miami Miller School of Medicine, FL.

Modifying 12 risk factors — alcohol and tobacco consumption, air pollution, head injury, poor education, hypertension, hearing impairment, obesity, depression, physical inactivity, poor social engagement, and diabetes — can lower the risk of Alzheimer’s disease by about 40%.2

Modifying and controlling 12 risk factors can lower the risk of Alzheimer’s disease by about 40%

Although other risk factors such as age, sex, genes, and family history cannot be controlled, individuals vary in their resilience or vulnerability to Alzheimer’s disease, added Professor Galvin. Resilience may offer protection from a poor environment, whereas vulnerability may be lessened by a good environment.

 

Measuring brain resilience and vulnerability to Alzheimer’s disease

Professor Galvin described tools he has developed with his colleagues to measure brain resilience and vulnerability to Alzheimer’s disease:

  • The Resilience Index (RI) provides a quantifiable measure of brain health and cognitive impairment3
  • The Vulnerability Index (VI) identifies individuals with a high risk for cognitive impairment4

A low RI or a high VI in asymptomatic individuals can inform personalized treatment plans to support brain health

The RI combines physical activity, cognitive activity, social engagements, dietary pattern, mindfulness, and cognitive reserve resulting in a range of scores from 1–378, explained Professor Galvin. It shows good discrimination between individuals with and without cognitive impairment (area under the curve [AUC] 0.836; 95% confidence interval [CI] 0.774–0.897).3-4

The VI combines 12 easily obtained modifiable and nonmodifiable sociodemographic, medical, and functional factors including age, sex, race, ethnicity, education, frailty, obesity, and medical comorbidities; and also accurately discriminates between individuals with and without cognitive impairment (AUC 0.844; 95% CI 0.776–0.913).

A low RI or a high VI in asymptomatic individuals can therefore inform personalized treatment plans to support brain health, concluded Professor Galvin.

 

BE-NOTPR-0266, approval date 04-2023

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References
  1. Agosta F, et al. Cortical remodeling across the lifespan in healthy brain reveals structural network vulnerability to neurodegeneration. Alzheimer’s Dementia 2022;17:e053492. https://doi.org/10.1002/alz.053492.
  2. Livingston G, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020;396:413–46.
  3. Galvin JE, et al. The Resilience Index: A quantifiable measure of brain health and risk of cognitive impairment and dementia. J Alzheimers Dis 2021;84:1729–46.
  4. Kleiman MJ, Galvin JE. The Vulnerability Index: A weighted measure of dementia and cognitive impairment risk. Alzheimer’s Dement 2021;13:e12249. https://doi.org/10.1002/dad2.12249.
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intended for health care professionals.
All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country